货号 (SKU)

包装规格

是否现货

价格

数量

Ab169301-100μg

100μg

现货

Ab169301-1mg

1mg

现货

Ab169301-5mg

5mg

现货

Ab169301-10mg

10mg

期货

基本信息

产品名称	Tremelimumab (anti-CTLA-4), 细胞毒性 T 淋巴细胞相关蛋白 4 (CD152) 抗体
别名	曲美木单抗 \| 特瑞莫单抗（抗CTLA-4）
英文别名	Tremelimumab \| Ticilimumab \| CP-675 \| 206 \| ALPS5 antibody \| CD 152 antibody \| CD antibody \| CD152 antibody \| CD152 antigen antibody \| CD152 isoform antibody \| Celiac disease 3 antibody \| CELIAC3 antibody \| CTLA 4 antibody \| CTLA-4 antibody \| CTLA4 antibo
规格或纯度	无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
宿主种属	人(Human)
特异性	CTLA-4 / CD152
应用	ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)
种属反应性	人(Human),食蟹猴(Cynomolgus monkey)
偶联	Unconjugated
作用类型	抑制剂
作用机制	细胞毒性 T 淋巴细胞相关蛋白 4 (CD152) 抗体

产品属性

克隆类型	重组抗体
Format	Whole IgG
亚型	Human IgG2
轻链亚型	kappa
SDS-PAGE	26.1 kDa (Light Chain) & 52.2 kDa (Heavy Chain), under reducing conditions; 178.0 kDa, under non-reducing conditions.
纯化方法	Protein A purified
纯度	>95%
来源	CHO supernatant
物理外观	Liquid
储存缓冲液	Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂	No
浓度	见COA
储存温度	-80℃储存,避免反复冻融
运输条件	超低温冰袋运输
稳定性与储存	在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
CAS编号和信息	745013-59-6
分子类型	抗体

图片

ELISA: Tremelimumab (anti-CTLA-4) (Ab169301)

Tremelimumab (anti-CTLA-4) (Ab169301) - ELISA
Immobilized Recombinant Human CTLA-4 Protein at 2 μg/mL can bind Tremelimumab (anti-CTLA-4) (Ab169301) with the EC₅₀ of 4.38 ng/mL.

SEC: Tremelimumab (anti-CTLA-4) (Ab169301)

Tremelimumab (anti-CTLA-4) (Ab169301) - SEC
The purity of Tremelimumab (anti-CTLA-4) (Ab169301) is more than 95% verified by HPLC.

关联靶点（人）

CTLA4 Tclin 细胞毒性T淋巴细胞蛋白4(Cytotoxic T-lymphocyte protein 4) (0 活性数据)

点击查看靶蛋白信息： CTLA4

活性类型	活性值-log(M)	作用机制	期刊	参考文献(PubMed IDs)

作用机制

作用机制	Action Type	target ID	Target Name	Target Type	Target Organism	Binding Site Name	参考文献

安全和危险性（GHS）

SDS英文版

质量标准

质量标准

质检证书（CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):

输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！

找到5个结果

批号(Lot Number)	证书类型	日期	货号
ZJ24F1012680	分析证书	24-10-23	Ab169301
ZJ24F1012769	分析证书	24-10-23	Ab169301
ZJ24F1012770	分析证书	24-10-23	Ab169301
ZJ23F1001509	分析证书	23-11-02	Ab169301
ZJ23F1001510	分析证书	23-11-02	Ab169301

可替换产品

参考文献

1. Reuben JM, Lee BN, Li C, Gomez-Navarro J, Bozon VA, Parker CA, Hernandez IM, Gutierrez C, Lopez-Berestein G, Camacho LH. (2006) Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma.. Cancer, 106 (11): (2437-44). [PMID:16615096]
2. Calabrò L, Morra A, Fonsatti E, Cutaia O, Fazio C, Annesi D, Lenoci M, Amato G, Danielli R, Altomonte M et al.. (2015) Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study.. Lancet Respir Med, 3 (4): (301-9). [PMID:25819643]
3. Joshua AM, Monzon JG, Mihalcioiu C, Hogg D, Smylie M, Cheng T. (2015) A phase 2 study of tremelimumab in patients with advanced uveal melanoma.. Melanoma Res, 25 (4): (342-7). [PMID:26050146]
4. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. (1991) CTLA-4 is a second receptor for the B cell activation antigen B7.. J Exp Med, 174 (3): (561-9). [PMID:1714933]
5. Harper, K K and 5 more authors.. (1991) CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location.. Journal of immunology (Baltimore, Md. : 1950), (1): [PMID:1713603]
6. Dariavach, P P, Mattéi, M G MG, Golstein, P P and Lefranc, M P MP.. (1988) Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains.. European journal of immunology, [PMID:3220103]
7. Metzler, W J WJ and 10 more authors.. (1997) Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28.. Nature structural biology, [PMID:9228944]
8. Marron, M P MP and 20 more authors.. (1997) Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups.. Human molecular genetics, [PMID:9259273]
9. Schneider, H H, Schwartzberg, P L PL and Rudd, C E CE.. (1998) Resting lymphocyte kinase (Rlk/Txk) phosphorylates the YVKM motif and regulates PI 3-kinase binding to T-cell antigen CTLA-4.. Biochemical and biophysical research communications, (9): [PMID:9813138]
10. Djilali-Saiah, I I and 5 more authors.. (1998) CTLA-4 gene polymorphism is associated with predisposition to coeliac disease.. Gut, [PMID:10189842]
11. Vaidya, B B and 6 more authors.. (1999) Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy.. Lancet (London, England), (28): [PMID:10475192]
12. Ling, V V and 5 more authors.. (1999) Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders.. Genomics, (15): [PMID:10493833]
13. Chikuma, S S, Murakami, M M, Tanaka, K K and Uede, T T.. (2000) Janus kinase 2 is associated with a box 1-like motif and phosphorylates a critical tyrosine residue in the cytoplasmic region of cytotoxic T lymphocyte associated molecule-4.. Journal of cellular biochemistry, [PMID:10842319]
14. Deng, Z Z and 11 more authors.. (2000) Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.. American journal of human genetics, [PMID:10903931]
15. Chistyakov, D A DA and 7 more authors.. (2000) Complex association analysis of graves disease using a set of polymorphic markers.. Molecular genetics and metabolism, [PMID:10924276]
16. Schwartz, J C JC, Zhang, X X, Fedorov, A A AA, Nathenson, S G SG and Almo, S C SC.. (2001) Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.. Nature, (29): [PMID:11279501]
17. Stamper, C C CC and 9 more authors.. (2001) Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses.. Nature, (29): [PMID:11279502]
18. Ling, V V and 9 more authors.. (2001) Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches.. Genomics, [PMID:11735222]
19. Ueda, Hironori H and 52 more authors.. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.. Nature, (29): [PMID:12724780]
20. Barreto, Marta M and 12 more authors.. (2004) Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus.. European journal of human genetics : EJHG, [PMID:15138458]
21. Thio, Chloe L CL and 8 more authors.. (2004) Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection.. Journal of virology, [PMID:15452244]
22. Hunt, Karen A KA and 8 more authors.. (2005) A common CTLA4 haplotype associated with coeliac disease.. European journal of human genetics : EJHG, [PMID:15657618]
23. Lee, Young Ho YH, Harley, John B JB and Nath, Swapan K SK.. (2005) CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis.. Human genetics, [PMID:15688186]
24. Darlington, Peter J PJ, Kirchhof, Mark G MG, Criado, Gabriel G, Sondhi, Jitin J and Madrenas, Joaquín J.. (2005) Hierarchical regulation of CTLA-4 dimer-based lattice formation and its biological relevance for T cell inactivation.. Journal of immunology (Baltimore, Md. : 1950), (15): [PMID:16002699]
25. Ribas, Antoni A and 8 more authors.. (2007) Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer.. The oncologist, [PMID:17673618]
26. Yang, James C JC and 12 more authors.. Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis.. Journal of immunotherapy (Hagerstown, Md. : 1997), [PMID:18049334]
27. Valk, Elke; Rudd, Christopher E and Schneider, Helga.. (2008) CTLA-4 trafficking and surface expression.. Trends in immunology, [PMID:18468488]
28. Gu, Ming M and 6 more authors.. (2008) Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis.. Clinical immunology (Orlando, Fla.), [PMID:18595775]
29. Linsley, Peter S PS and Nadler, Steven G SG.. (2009) The clinical utility of inhibiting CD28-mediated costimulation.. Immunological reviews, [PMID:19426230]
30. Yu, Chao and 11 more authors.. (2011) Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering.. The Journal of biological chemistry, (25): [PMID:21156796]
31. Kuehn, Hye Sun HS and 35 more authors.. (2014) Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.. Science (New York, N.Y.), (26): [PMID:25213377]
32. Schubert, Desirée D and 39 more authors.. (2014) Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.. Nature medicine, [PMID:25329329]

溶液计算器

摩尔浓度计算器

计算溶液所需的质量、体积或浓度。

质量

浓度

体积

分子量

g/mol

稀释计算器

计算配制储备溶液所需的稀释度。

浓度1（C1）

体积 1 (V1)

浓度 2 (C2)

体积 2 (V2)

复溶计算器

复溶计算器允许您快速计算试剂的体积，以复溶小瓶。只需输入试剂的质量和目标浓度，计算器将确定其余部分。

体积（添加到小瓶中）

质量（小瓶）

所需的复溶浓度

Tremelimumab (anti-CTLA-4), 细胞毒性 T 淋巴细胞相关蛋白 4 (CD152) 抗体

库存信息

库存信息

库存信息

库存信息

基本信息

产品属性

图片

关联靶点（人）

作用机制

安全和危险性（GHS）

质量标准

质检证书（CoA,COO,BSE/TSE 和分析图谱)

可替换产品

参考文献

溶液计算器

摩尔浓度计算器

稀释计算器

复溶计算器

Tremelimumab (anti-CTLA-4), 细胞毒性 T 淋巴细胞相关蛋白 4 (CD152) 抗体

库存信息

库存信息

库存信息

库存信息

基本信息

产品属性

图片

关联靶点（人）

作用机制

安全和危险性（GHS）

质量标准

质检证书（CoA,COO,BSE/TSE 和分析图谱)

相关产品

可替换产品

参考文献

溶液计算器

摩尔浓度计算器

稀释计算器

复溶计算器